Fasching PA - Search Results

1

Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk.

Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernández-Navarro P, Gonzalez-Neira A, Benitez J, van Gils CH, Lokate M, Onland-Moret NC, Peeters PH, Brown J, Leyland J, Varghese JS, Easton DF, Thompson DJ, Luben RN, Warren RM, Wareham NJ, Loos RJ, Khaw KT, Ursin G, Lee E, Gayther SA, Ramus SJ, Eeles RA, Leach MO, Kwan-Lim G, Couch FJ, Giles GG, Baglietto L, Krishnan K, Southey MC, Le Marchand L, Kolonel LN, Woolcott C, Maskarinec G, Haiman CA, Walker K, Johnson N, McCormack VA, Biong M, Alnaes GI, Gram IT, Kristensen VN, Børresen-Dale AL, Lindström S, Hankinson SE, Hunter DJ, Andrulis IL, Knight JA, Boyd NF, Figuero JD, Lissowska J, Wesolowska E, Peplonska B, Bukowska A, Reszka E, Liu J, Eriksson L, Czene K, Audley T, Wu AH, Pankratz VS, Hopper JL, dos-Santos-Silva I. Vachon CM, et al. Among authors: fasching pa. Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1156-66. doi: 10.1158/1055-9965.EPI-12-0066. Epub 2012 Mar 27. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22454379 Free PMC article.

2

Demographic and psychosocial factors associated with risk perception for breast cancer.

Pöhls UG, Fasching PA, Beck H, Kaufmann M, Kiechle M, von Minckwitz G, Paepke S, Schultz-Zehden B, Schwarz-Boeger U, Beckmann MW. Pöhls UG, et al. Among authors: fasching pa. Oncol Rep. 2005 Dec;14(6):1605-13. Oncol Rep. 2005. PMID: 16273264

3

Hereditary breast and ovarian cancer: review and future perspectives.

Lux MP, Fasching PA, Beckmann MW. Lux MP, et al. Among authors: fasching pa. J Mol Med (Berl). 2006 Jan;84(1):16-28. doi: 10.1007/s00109-005-0696-7. Epub 2005 Nov 11. J Mol Med (Berl). 2006. PMID: 16283147 Review.

4

Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics.

Fasching PA, Heusinger K, Loehberg CR, Wenkel E, Lux MP, Schrauder M, Koscheck T, Bautz W, Schulz-Wendtland R, Beckmann MW, Bani MR. Fasching PA, et al. Eur J Radiol. 2006 Dec;60(3):398-404. doi: 10.1016/j.ejrad.2006.08.002. Epub 2006 Oct 9. Eur J Radiol. 2006. PMID: 17030108

5

The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs.

Fasching PA, von Minckwitz G, Fischer T, Kaufmann M, Schultz-Zehden B, Beck H, Lux MP, Jacobs V, Meden H, Kiechle M, Beckmann MW, Paepke S. Fasching PA, et al. Breast Cancer Res Treat. 2007 Jan;101(1):95-104. doi: 10.1007/s10549-006-9272-2. Epub 2006 Oct 11. Breast Cancer Res Treat. 2007. PMID: 17033928

6

Hormones and genetics caught in the crossfire of preventive medicine.

Fasching PA, Beckmann MW. Fasching PA, et al. Lancet Oncol. 2007 Jan;8(1):5-6. doi: 10.1016/S1470-2045(06)70987-1. Lancet Oncol. 2007. PMID: 17196506 No abstract available.

7

Evaluation of mathematical models for breast cancer risk assessment in routine clinical use.

Fasching PA, Bani MR, Nestle-Krämling C, Goecke TO, Niederacher D, Beckmann MW, Lux MP. Fasching PA, et al. Eur J Cancer Prev. 2007 Jun;16(3):216-24. doi: 10.1097/CEJ.0b013e32801023b3. Eur J Cancer Prev. 2007. PMID: 17415092

8

Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer.

Schrauder M, Frank S, Strissel PL, Lux MP, Bani MR, Rauh C, Sieber CC, Heusinger K, Hartmann A, Schulz-Wendtland R, Strick R, Beckmann MW, Fasching PA. Schrauder M, et al. Among authors: fasching pa. J Cancer Res Clin Oncol. 2008 Aug;134(8):873-82. doi: 10.1007/s00432-008-0355-9. Epub 2008 Feb 9. J Cancer Res Clin Oncol. 2008. PMID: 18264724

9

Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk.

Renner SP, Strick R, Fasching PA, Oeser S, Oppelt P, Mueller A, Beckmann MW, Strissel PL. Renner SP, et al. Among authors: fasching pa. Am J Obstet Gynecol. 2008 Dec;199(6):648.e1-9. doi: 10.1016/j.ajog.2008.06.015. Epub 2008 Aug 8. Am J Obstet Gynecol. 2008. PMID: 18691687

10

Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen.

Strissel PL, Ellmann S, Loprich E, Thiel F, Fasching PA, Stiegler E, Hartmann A, Beckmann MW, Strick R. Strissel PL, et al. Among authors: fasching pa. Int J Cancer. 2008 Dec 15;123(12):2871-9. doi: 10.1002/ijc.23900. Int J Cancer. 2008. PMID: 18814240 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

810 results

Search Page